These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 17505298)
21. Novel derivatives of polymyxins. Vaara M J Antimicrob Chemother; 2013 Jun; 68(6):1213-9. PubMed ID: 23412346 [TBL] [Abstract][Full Text] [Related]
22. Infections in a surgical intensive care unit of a university hospital in Greece. Markogiannakis H; Pachylaki N; Samara E; Kalderi M; Minettou M; Toutouza M; Toutouzas KG; Theodorou D; Katsaragakis S Int J Infect Dis; 2009 Mar; 13(2):145-53. PubMed ID: 18775663 [TBL] [Abstract][Full Text] [Related]
23. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients? Eachempati SR; Hydo LJ; Shou J; Barie PS J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237 [TBL] [Abstract][Full Text] [Related]
24. Role of the infectious diseases specialist consultant on the appropriateness of antimicrobial therapy prescription in an intensive care unit. Raineri E; Pan A; Mondello P; Acquarolo A; Candiani A; Crema L Am J Infect Control; 2008 May; 36(4):283-90. PubMed ID: 18455049 [TBL] [Abstract][Full Text] [Related]
25. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved? Bhat S; Fujitani S; Potoski BA; Capitano B; Linden PK; Shutt K; Paterson DL Int J Antimicrob Agents; 2007 Nov; 30(5):458-62. PubMed ID: 17703923 [TBL] [Abstract][Full Text] [Related]
26. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study. Deal EN; Micek ST; Reichley RM; Ritchie DJ Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902 [TBL] [Abstract][Full Text] [Related]
27. Microbiologic spectrum and susceptibility pattern of clinical isolates from the pediatric intensive care unit in a single medical center - 6 years' experience. Lee CY; Chen PY; Huang FL; Lin CF J Microbiol Immunol Infect; 2009 Apr; 42(2):160-5. PubMed ID: 19597649 [TBL] [Abstract][Full Text] [Related]
29. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics]. Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430 [TBL] [Abstract][Full Text] [Related]
30. Trends in antimicrobial susceptibility of Gram-negative isolates from a paediatric intensive care unit in Warsaw: results from the MYSTIC programme (1997-2007). Patzer JA; Dzierzanowska D; Turner PJ J Antimicrob Chemother; 2008 Aug; 62(2):369-75. PubMed ID: 18445575 [TBL] [Abstract][Full Text] [Related]
31. Polymyxin B: similarities to and differences from colistin (polymyxin E). Kwa A; Kasiakou SK; Tam VH; Falagas ME Expert Rev Anti Infect Ther; 2007 Oct; 5(5):811-21. PubMed ID: 17914915 [TBL] [Abstract][Full Text] [Related]
32. Optimizing therapy for Acinetobacter baumannii. Peleg AY Semin Respir Crit Care Med; 2007 Dec; 28(6):662-71. PubMed ID: 18095230 [TBL] [Abstract][Full Text] [Related]
33. In vitro activities of 'new' and 'conventional' antibiotics against multi-drug resistant Gram negative bacteria from patients in the intensive care unit. Ratnam I; Franklin C; Spelman DW Pathology; 2007 Dec; 39(6):586-8. PubMed ID: 18027263 [TBL] [Abstract][Full Text] [Related]
34. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria. Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989 [TBL] [Abstract][Full Text] [Related]
35. Polymyxins and their novel derivatives. Vaara M Curr Opin Microbiol; 2010 Oct; 13(5):574-81. PubMed ID: 20869908 [TBL] [Abstract][Full Text] [Related]
36. Impact of multiresistance of gram-negative bacteria in bloodstream infection on mortality rates and length of stay. Sostarich AM; Zolldann D; Haefner H; Luetticken R; Schulze-Roebecke R; Lemmen SW Infection; 2008 Feb; 36(1):31-5. PubMed ID: 18231721 [TBL] [Abstract][Full Text] [Related]
37. Cooperative action of SP-A and its trimeric recombinant fragment with polymyxins against Gram-negative respiratory bacteria. Coya JM; Fraile-Ágreda V; de Tapia L; García-Fojeda B; Sáenz A; Bengoechea JA; Kronqvist N; Johansson J; Casals C Front Immunol; 2022; 13():927017. PubMed ID: 36159837 [TBL] [Abstract][Full Text] [Related]
38. Investigation of colistin sensitivity via three different methods in Acinetobacter baumannii isolates with multiple antibiotic resistance. Sinirtaş M; Akalin H; Gedikoğlu S Int J Infect Dis; 2009 Sep; 13(5):e217-20. PubMed ID: 19230734 [TBL] [Abstract][Full Text] [Related]
39. Reviving Polymyxins: Achievements, Lessons and the Road Ahead. Li J Adv Exp Med Biol; 2019; 1145():1-8. PubMed ID: 31364067 [TBL] [Abstract][Full Text] [Related]
40. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients. Ghosh A; Karmakar PS; Pal J; Chakraborty N; Debnath NB; Mukherjee JD J Indian Med Assoc; 2009 Jan; 107(1):21-2, 24-5. PubMed ID: 19588683 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]